Yahoo! Finance: OMPI News

Latest Financial News for Obagi Medical Products, Inc.

• OBAGI MEDICAL PRODUCTS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an (EDGAR Online)

  (Wed, 26 Nov 2008 11:04:02 Etc/GMT)

• 5-Star Stocks on the Upswing (at Motley Fool)

  (Thu, 20 Nov 2008 19:43:21 Etc/GMT)

• Obagi Medical Products, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha)

  (Thu, 20 Nov 2008 18:04:16 Etc/GMT)

• OBAGI MEDICAL PRODUCTS, INC. Financials (EDGAR Online Financials)

  (Thu, 13 Nov 2008 14:04:46 Etc/GMT)

• OBAGI MEDICAL PRODUCTS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)

  (Fri, 7 Nov 2008 11:04:29 Etc/GMT)

• UPDATE - Obagi Medical Q3 profit falls; Q4 outlook cut (at Reuters)

  (Thu, 6 Nov 2008 22:35:19 Etc/GMT)

• Syniverse Hldg, AnnTaylor Stores and Warnaco Group among 52-week lows (SmallCapInvestor.com)

  (Thu, 6 Nov 2008 21:31:45 Etc/GMT)

• OBAGI MEDICAL PRODUCTS INC Earnings Call scheduled for 4:30 pm ET today (CCBN)

  (Thu, 6 Nov 2008 21:30:00 Etc/GMT)

• OBAGI MEDICAL PRODUCTS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)

  (Thu, 6 Nov 2008 21:04:26 Etc/GMT)

• Obagi Medical Products Reports Third Quarter 2008 Financial Results (Business Wire)

  (Thu, 6 Nov 2008 21:00:00 Etc/GMT)

  LONG BEACH, Calif.----Obagi Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the third quarter and nine months ended September 30, 2008.

Yahoo! Finance: OMPI Financial Blogs

Latest Financial Financial Blogs for Obagi Medical Products, Inc.

MSN Money News - OMPI

News about Obagi Medical Products?Inc

• Obagi Medical Products Reports Third Quarter 2008

  (Thursday, November 06, 2008 4:00 PM)

  Obagi Medical Products, Inc. (NASDAQ:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the third quarter and nine months ended September

• 5-Star Stocks on the Upswing

  (Wednesday, November 05, 2008 12:10 PM)

  Check out these newly minted five-star stocks.

• New Study Finds Obagi Medical Products' ELASTIder

  (Tuesday, October 28, 2008 11:30 AM)

  Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of its copper-zinc malonate eye treatment

• Obagi Medical Products to Report Third Quarter 20

  (Thursday, October 23, 2008 4:00 PM)

  Obagi Medical Products, Inc. (Nasdaq:OMPI), today announced third quarter 2008 financial results will be released after market close on Thursday, November 6 and will be followed by an investor

• Obagi Medical Products' ELASTIderm Decolletage Sy

  (Thursday, October 16, 2008 8:00 AM)

  Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced positive study results at the Fall Clinical Dermatology

• Obagi Medical Products to Present at the Maxim Gr

  (Tuesday, September 23, 2008 4:05 PM)

  Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Company management will present a corporate overview at the Maxim

OMPI - News and Analysis from Seeking Alpha

'OMPI' Tag RSS Syndication from SeekingAlpha.com

• Obagi Medical Products, Inc. Q3 2008 Earnings Call Transcript

  (Thu, 20 Nov 2008 13:04:16 -0500)

  Obagi Medical Products, Inc. (OMPI)

  Q3 2008 Earnings Call Transcript

  
  Complete Story »

• Obagi Medical Products, Inc. Q2 2008 Earnings Call Transcript

  (Mon, 11 Aug 2008 14:00:29 -0400)

  Obagi Medical Products, Inc. (OMPI)

  Q2 2008 Earnings Call

  
  Complete Story »

• Obagi Medical Products, Inc. Q1 2008 Earnings Call Transcript

  (Mon, 05 May 2008 20:01:07 -0400)

  Obagi Medical Products, Inc. (OMPI)

  Q1 2008 Earnings Call

  
  Complete Story »

• Obagi Medical Should Jump on Bullish Calls

  (Mon, 28 Apr 2008 09:41:50 -0400)

  Notable Calls submits:

  Obagi Medical (NASDAQ:OMPI) is getting mega-comments from two firms this morning ahead of their Q1 report scheduled for May 5:

  - Baird & Co reaffirms their Outperform rating and recommends purchase ahead of the Q1 report. They conducted a survey in 12 US cities to assess demand for physician-dispensed products. Firm's survey results indicate that demand for these products is roughly comparable to six months ago. Firm believes the market has priced in too much pessimism; buy ahead of quarter.

  
  Complete Story »

• Obagi Medical Products, Inc. Q4 2007 Earnings Call Transcript

  (Mon, 03 Mar 2008 20:27:07 -0500)

  Obagi Medical Products, Inc. (OMPI)

  Q4 2007 Earnings Call

  
  Complete Story »

• Obagi Medical Products: Imperfections Despite Looking Great

  (Fri, 30 Nov 2007 02:52:38 -0500)

  Obagi Medical Products, Inc. (Nasdaq: OMPI) wants to keep you looking young even though you are old. The skin care industry thrives mainly on faith and fantasy, or at least the softening of mean facts: a wrinkle becomes a soft tissue deficit. Obagi says it can repair these epidermal shortcomings even as the rest of you falls apart.

  The company counts on customers similar to 1950's Sunset Boulevard?s Norma Desmond, who couldn?t bear her tissue deficits, or her age, which was fifty; it drove her mad. Apparently, there are plenty of Normas (and a few Normans) still around. The global skin-care market was at $36.2 billion in 2005, and...

• Obagi Medical Products Q3 2007 Earnings Call Transcript

  (Tue, 13 Nov 2007 22:14:15 -0500)

  Obagi Medical Products, Inc. (OMPI)

  
  Complete Story »

• This Week's IPOs, Part I: Artes Medical, Carrols Restaurant Group, Double-Take Software, MEDecision, Obagi Medical

  (Sun, 10 Dec 2006 13:29:23 -0500)

  Abbi Adest submits:Some of the IPOs on deck for this week include: Artes Medical (ARTE), a medical technology firm developing injectable aesthetic products for the dermatology and plastic surgery markets; Carrols Restaurant Group (TAST), which operates 542 Burger King, Pollo Tropical and Taco Cabana restaurants; Double-Take Software (DBTK), which makes affordable replication data protection software for Microsoft servers; MEDecision (MEDE), a provider of software and services to increase efficiencies of healthcare insurers; and Obagi Medical Products (OMPI), a maker of topical skincare products to treat various skin conditions.

  All quotations are from the companies' most recent S-1 filings with links...

• Pharma IPO: Highlights from Obagi Medical's S-1 Filing

  (Thu, 14 Sep 2006 23:56:14 -0400)

  Skincare products manufacturer Obagi Medical filed an S-1 with the SEC this week. Highlights and excerpts from the company's filing:

  Proposed Ticker: (OMPI)

  Underwriters: JPMorgan, CIBC World Markets, Thomas Weisel, Robert W. Baird

  
  Complete Story »

Investor Clicks Financial Advertising

News for Obagi Medical Products, Inc. - Google Finance

News for Obagi Medical Products, Inc. - Google Finance

• Diagnostic and Therapeutic Challenges of Acute Migraine

  (Thu, 27 Nov 2008 17:22:43 GMT)
  Diagnostic and Therapeutic Challenges of Acute Migraine
  Medscape - Nov 27, 2008

  Disclosure: Frederick Freitag, DO, has disclosed that he has conducted research for Advanced Bionics, AstraZeneca, GlaxoSmithKline, Merck, and Ortho-McNeil Neurologics. Dr. Freitag has also ...

• UPDATE 1-Obagi Medical Q3 profit falls; Q4 outlook cut

  (Thu, 06 Nov 2008 22:57:37 GMT)
  UPDATE 1-Obagi Medical Q3 profit falls; Q4 outlook cut
  Forbes - Nov 6, 2008

  Nov 6 (Reuters) - Obagi Medical Products (nasdaq: OMPI - news - people ) Inc reported a lower quarterly profit on flat sales and higher expenses, and slashed its fourth-quarter outlook, citing ...

• Obagi Medical Products Reports Third Quarter 2008 Financial Results

  (Thu, 06 Nov 2008 21:22:58 GMT)
  Obagi Medical Products Reports Third Quarter 2008 Financial Results
  International Business Times - Nov 6, 2008

  Obagi Medical Products, Inc. (NASDAQ:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the third quarter and nine months ended ...

• OMPI: Data re ELASTIderm(TM) Published in Experimental Dermatology Journal

  (Tue, 28 Oct 2008 16:19:57 GMT)
  OMPI: Data re ELASTIderm(TM) Published in Experimental Dermatology Journal
  Trading Markets (press release) - Oct 28, 2008

  Obagi Medical Products, Inc. (OMPI) announced the publication of a study of its copper-zinc malonate eye treatment ELASTIderm(TM) in the September 2008 issue of Experimental Dermatology, a premier ...

• New Study Finds Obagi Medical Products? ELASTIderm Eye Treatment Regenerates Elastic Fibers in Skin around the Eyes

  (Tue, 28 Oct 2008 15:33:42 GMT)
  New Study Finds Obagi Medical Products? ELASTIderm Eye Treatment Regenerates Elastic Fibers in Skin around the Eyes
  Business Wire (press release) - Oct 28, 2008

  LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of ...

  New Study Finds Obagi Medical Products' ELASTIderm Eye Treatment Regenerates Elastic Fibers in Skin around - PR-Inside.com (Pressemitteilung)
  

• Obagi Medical Products to Report Third Quarter 2008 Financial Results and Host a Conference Call on November 6

  (Thu, 23 Oct 2008 20:06:40 GMT)
  Obagi Medical Products to Report Third Quarter 2008 Financial Results and Host a Conference Call on November 6
  Business Wire (press release) - Oct 23, 2008

  LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), today announced third quarter 2008 financial results will be released after market close on Thursday, November 6 ...

  Obagi Medical Schedules Release, Call - Trading Markets (press release)
  

• Susquehanna Downgrades Obagi Medical Products (OMPI) to Neutral

  (Thu, 23 Oct 2008 12:57:08 GMT)
  Susquehanna Downgrades Obagi Medical Products (OMPI) to Neutral
  StreetInsider.com (subscription) - Oct 23, 2008

  Susquehanna analyst says, "We are decreasing our growth expectations on OMPI due to the economic environment and consumer sensitivity for the company's products. Given the current depressed state ...

• Obagi Medical Products? ELASTIderm Décolletage System Reduces Visible Signs of Aging on Chest and Neck

  (Thu, 16 Oct 2008 12:05:18 GMT)
  Obagi Medical Products? ELASTIderm Décolletage System Reduces Visible Signs of Aging on Chest and Neck
  Business Wire (press release) - Oct 16, 2008

  LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced positive study results at the ...

  Obagi Medical Products' ELASTIderm Decolletage System Reduces Visible Signs of Aging on Chest and Neck - Ad-Hoc-News (Pressemitteilung)
  

• OMPI: To Present At Maxim Group Growth Conference @ 14:00 ET [delayed]

  (Tue, 07 Oct 2008 16:29:22 GMT)
  OMPI: To Present At Maxim Group Growth Conference @ 14:00 ET [delayed]
  Trading Markets (press release) - Oct 7, 2008

  Ridgeland, MS, OCT 07, 2008 (EventX/Knobias.com via COMTEX) -- OMPI | Quote | Chart | News | PowerRating -- Company representatives of Obagi Medical Products Inc (NasdaqNM: OMPI | Quote | Chart ...

• Obagi Medical Products to Present at the Maxim Group Growth Conference

  (Tue, 23 Sep 2008 20:08:08 GMT)
  Obagi Medical Products to Present at the Maxim Group Growth Conference
  Business Wire (press release) - Sep 23, 2008

  LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today announced that Company management will ...

MarketWatch.com - All MarketWatch News - OMPI

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.

• Mark Hulbert: Playing a Santa rally is harder than it looks

  (Mon, 03 Dec 2007 12:01:00 -0500)

  ANNANDALE, Va. (MarketWatch) -- Profiting from the stock market's positive year-end seasonal tendencies certainly looks easy.

• The Technical Indicator: Despite pullback, S&P making a stand at 1,540

  (Fri, 19 Oct 2007 09:48:00 -0500)

  Friday's analysis

• Obagi Medical cut to neutral at J.P. Morgan

  (Thu, 10 May 2007 09:18:32 -0500)

• Movers & Shakers: Tuesday's biggest stock gainers and decliners

  (Tue, 23 Jan 2007 06:10:00 -0500)

  Highlights of rising and falling U.S. stocks

• Obagi Medical Products started at overweight: Thomas Weisel

  (Tue, 23 Jan 2007 10:42:06 -0500)

• Obagi Medical Prod. started at sector outperformer at CIBC

  (Tue, 23 Jan 2007 09:27:42 -0500)

• IPO Report: IPO market cools down after year-end sprint

  (Thu, 21 Dec 2006 03:37:00 -0500)

  NEW YORK (MarketWatch) -- The market for initial public offerings has finally cooled off, with a weak debutante performance from Solarfun capping a flurry of 27 news issues in December.

• Movers & Shakers: Thursday's biggest stock gainers and decliners

  (Thu, 14 Dec 2006 06:18:00 -0500)

  Thursday's biggest stock gainers and decliners

• IPO Report: Genesis Lease raises $641 million in busy IPO day

  (Thu, 14 Dec 2006 02:54:00 -0500)

  NEW YORK (MarketWatch) -- Genesis Lease Ltd. shares rose in their stock market debut as the plane-leasing firm raised $641 million in another busy day for initial public offerings Thursday.

• Obagi Medical Products IPO trades at $11, flat w/ price

  (Thu, 14 Dec 2006 10:42:27 -0500)

Only registered users can write comments.
Please login or register.

---